ANDREONE, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 14.479
EU - Europa 9.051
AS - Asia 4.760
AF - Africa 544
SA - Sud America 26
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.879
Nazione #
US - Stati Uniti d'America 14.437
GB - Regno Unito 2.753
CN - Cina 1.768
SE - Svezia 1.518
SG - Singapore 1.176
DE - Germania 1.169
VN - Vietnam 1.032
IT - Italia 965
RU - Federazione Russa 570
IN - India 499
UA - Ucraina 468
IE - Irlanda 414
FR - Francia 354
ZA - Sudafrica 211
EE - Estonia 206
TG - Togo 173
CH - Svizzera 135
JO - Giordania 126
BG - Bulgaria 98
GR - Grecia 93
BE - Belgio 90
CI - Costa d'Avorio 77
FI - Finlandia 74
NG - Nigeria 42
NL - Olanda 40
CA - Canada 39
SC - Seychelles 35
IR - Iran 32
JP - Giappone 22
PL - Polonia 21
AT - Austria 17
LB - Libano 17
ID - Indonesia 16
BR - Brasile 14
HK - Hong Kong 13
KR - Corea 12
AU - Australia 11
ES - Italia 10
MY - Malesia 10
CL - Cile 9
CZ - Repubblica Ceca 9
HR - Croazia 9
UZ - Uzbekistan 9
RO - Romania 8
DK - Danimarca 7
PT - Portogallo 6
MK - Macedonia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
IL - Israele 4
BD - Bangladesh 3
EC - Ecuador 3
EU - Europa 3
NO - Norvegia 3
PH - Filippine 3
RS - Serbia 3
TH - Thailandia 3
TR - Turchia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
MM - Myanmar 2
UG - Uganda 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
GE - Georgia 1
GL - Groenlandia 1
IQ - Iraq 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
SI - Slovenia 1
SM - San Marino 1
Totale 28.879
Città #
Southend 2.522
Fairfield 1.997
Chandler 1.245
Ashburn 1.123
Singapore 1.033
Houston 986
Woodbridge 952
Seattle 880
Wilmington 795
Dong Ket 740
Cambridge 668
Ann Arbor 666
Princeton 591
Santa Clara 583
Dublin 412
Boardman 366
Jacksonville 275
Westminster 270
Nanjing 254
Padova 219
Bologna 185
Lomé 173
Berlin 149
Jinan 132
Amman 126
San Diego 124
Shenyang 118
Saint Petersburg 116
Beijing 113
Bern 111
Sofia 96
Brussels 89
Abidjan 77
Tianjin 75
Helsinki 72
Changsha 71
Nanchang 69
New York 69
Hebei 67
Turin 66
Guangzhou 61
Florence 58
Redmond 58
Bremen 57
Medford 55
Mülheim 53
Dearborn 49
Milan 49
Jiaxing 48
Falls Church 45
Norwalk 44
Yubileyny 43
Abeokuta 41
Des Moines 39
Los Angeles 37
Hangzhou 36
Mahé 35
Ningbo 35
Shanghai 34
Zhengzhou 33
Phoenix 27
Wuhan 27
Frankfurt am Main 26
Haikou 26
Redwood City 26
Taizhou 24
Tokyo 22
Olalla 21
Fuzhou 20
Lanzhou 20
London 20
Toronto 20
Washington 20
Kunming 18
Paris 18
Falkenstein 17
Frankfurt Am Main 17
Verona 16
Athens 15
Buffalo 15
Moscow 15
Mountain View 15
Taiyuan 15
Bühl 13
Costa Mesa 13
Andover 12
Chengdu 12
Jakarta 12
Leawood 12
North York 12
Rome 12
San Francisco 11
San Venanzo 11
Shenzhen 11
Amsterdam 10
Ardabil 10
Grafing 10
Kuala Lumpur 10
São Paulo 10
Chicago 9
Totale 20.235
Nome #
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 225
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 216
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 208
Adaptive response in Hepatitis B virus infection 202
ABT-450: A novel agent for the treatment of CHC genotype 1: Focus on treatment-experienced patients 192
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 180
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection. 179
Clinical and serological profile of primary biliary cirrhosis in men. 179
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 176
Alcohol and viral hepatitis: a mini-review. 173
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 172
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation. 167
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 166
Anti-synthetase syndrome with lung involvement associated with primary biliary cirrhosis: A case report 164
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 161
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned. 160
Working together to tackle HCV infection: Ombitasvir/paritaprevir/ritonavir and dasabuvir combination 159
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 158
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 156
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 156
Safety and efficacy of once daily ledipasvir/sofosbuvir fixed-dose combination in patients with chronic hepatitis C 155
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 154
Treating hepatitis C in the elderly: the future is near? 153
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 153
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives 153
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 153
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 153
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. 152
Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise 151
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 151
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 151
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 149
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 148
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 147
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 147
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 145
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 144
Grazoprevir/elbasvir fixed-dose combination for hepatitis C 144
Nivolumab-induced cholangitic liver disease: A novel form of serious liver injury 144
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 143
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 140
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 140
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 139
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 139
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 138
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 138
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 138
Chronic hepatitis B: Are we close to a cure? 138
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 138
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B 137
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 136
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 135
Vitamins in the treatment of chronic viral hepatitis. 135
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 135
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 134
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 134
Bipolar and related disorders induced by sodium 4-phenylbutyrate in a male adolescent with bile salt export pump deficiency disease 133
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 132
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Liver transplantation for patients with alcoholic liver disease: an open question 129
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 129
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 129
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 128
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 127
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 127
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 126
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 126
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a 125
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 125
ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection 125
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 125
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 125
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance. 124
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 124
Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis 124
Gamma-hydroxybutyric acid plus naltrexone in the treatment of alcoholics resistant to monotherapy. 123
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 123
Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B 123
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 123
Authors’ reply: Comment to “Liver transplantation for patients with alcoholic liver disease: An open question” 123
Multidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver Disease 123
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. 122
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 122
Hepatitis B virus and immune response. 121
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. 121
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 121
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 121
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 120
Non-alcoholic steatohepatitis and liver transplantation 120
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 119
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 119
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 118
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 118
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 118
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 118
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" 117
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 117
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 117
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 117
Terapia cellulare in Epatologia 116
Totale 14.146
Categoria #
all - tutte 78.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.298 0 0 0 0 0 0 0 1.018 1.078 485 262 455
2020/20213.763 782 307 133 124 71 157 64 220 328 214 178 1.185
2021/20225.350 507 182 367 460 465 305 90 343 193 373 1.216 849
2022/20235.275 619 800 277 721 298 402 154 261 913 153 416 261
2023/20241.256 95 240 111 111 110 244 55 110 40 63 36 41
2024/20253.522 164 946 414 493 882 286 283 54 0 0 0 0
Totale 29.476